Clinical trial

The Role of Epidural Opioids in Pain Management After Abdominal Surgery in Adult Patients - a Randomized Clinical Trial

Name
0489-19-TLV
Description
It is unclear whether addition of opioids to epidural solutions for postoperative analgesia is beneficial. In this multicenter randomized double-blinded trial, we aim to test the primary hypothesis that epidural solutions containing only bupivacaine are as effective as solutions containing both bupivacaine and fentanyl in promoting analgesia in patients recovering from open abdominal surgery. We also aim to assess the incidence of epidural-induced hypotension, the difference in patient-reported opioid side-effects between the two groups. If we demonstrate no clinically important difference between the two interventions, clinicians will be able to substantially reduce the amount of opioids patients receive during their postoperative recovery, and potentially decrease the associated high incidence of opioid adverse effects in post-surgical patients.
Trial arms
Trial start
2020-08-01
Estimated PCD
2022-03-02
Trial end
2022-03-02
Status
Completed
Phase
Early phase I
Treatment
Bupivacaine
epidural solution containing bupivacaine 0.1% in normal saline
Arms:
Bupivacaine, Bupivacaine + Fentanyl
Other names:
Marcaine
Fentanyl
Epidural solution containing fentanyl 3 mcg/ml (in addition to bupivacaine) in normal saline
Arms:
Bupivacaine + Fentanyl
Other names:
Beatryl
Size
135
Primary endpoint
Postoperative analgesia
48 postoperative hours
Eligibility criteria
Inclusion Criteria: 1. Written informed consent 2. 18-85 years old 3. Undergoing open abdominal surgery (including colorectal, intestinal, gastric, pancreatic, hepatobiliary, urological, or gynecological surgery) 4. For which a clinical decision has been made to provide epidural analgesia preoperatively and extending to the post-operative period 5. Anticipated hospitalization of at least 2 nights Exclusion Criteria: 1. Known allergy to bupivacaine or fentanyl 2. Chronic liver disease, defined as cirrhosis, portal hypertension, or variceal bleeding 3. Patients under chronic alpha-blocking agents for hypertension 4. Clinical contraindications to epidural introduction, as judged by the anesthesia provider (thrombocytopenia, un-interrupted anticoagulation, clinically-significant atrio-ventricular conduction block, etc.) 5. Pregnant women
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE4'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'SUPPORTIVE_CARE', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 135, 'type': 'ACTUAL'}}
Updated at
2023-04-12

1 organization

1 product

1 drug

1 indication